I Bought Atlassian Stock When It Was Down 87%, and Now It's Soaring. These Were My Reasons.

Atlassian reported Q3 FY2026 revenue of $1.8 billion, up 32% year over year and ahead of the $1.7 billion consensus, with growth accelerating from 23% in the prior quarter. The article argues AI is a tailwind rather than a threat, highlighting Rovo, strong customer adoption, and a 3.7x price-to-sales multiple that is near its cheapest since the 2015 IPO. The stock had already rebounded about 50% from its low, and the WSJ-tracked average price target of $125.07 implies roughly 40% additional upside.

Analysis

The market is still treating AI as a replacement shock to workflow software, but the more probable near-term effect is augmentation: copilots increase usage intensity, widen seat-level engagement, and make the platform stickier. That matters because collaboration software is not bought purely on features; it is bought on integration depth, admin trust, and switching friction, all of which become more valuable when teams want an AI layer across scattered enterprise data. The second-order winner is whoever can turn proprietary usage data into a better assistant faster than generic model providers can commoditize the interface.

The key read-through is that the company is no longer being valued like a fading seat-based utility; the re-rating is likely to come from durable ARR expansion per customer rather than net-new logo growth. If AI usage raises attach rates on premium modules and enterprise governance, the upside is multiplicative because gross margin can improve while support and cloud costs stay relatively fixed. That said, this is still a sentiment-sensitive name: the stock can give back a large part of the move if future quarters show monetization lagging behind product adoption.

Consensus appears to be underestimating how expensive it is for large regulated enterprises to replace a platform once security, identity, and audit requirements are layered in. Internal-build substitutes look cheap in demos but become costly when you include bug-fix staffing, compliance, uptime, and liability; that makes the competitive moat wider in banking, healthcare, and software development than in generic productivity use cases. The main risk is not AI disintermediation but execution: if AI features remain additive without meaningful pricing uplift, the market could compress the multiple again over the next 1-2 quarters.

The cleaner setup is a momentum-plus-fundamental confirmation trade, not a blind multiple expansion bet. If next earnings show continued acceleration and higher Rovo attach, the stock can work toward the consensus target; if growth re-accelerates but guidance stays cautious, expect volatility as short interest unwinds and then stalls. The best bearish counter is not shorting the name outright, but fading any post-earnings gap if management fails to prove AI monetization is moving from engagement to revenue.

Key Decisions for Investors

• Go long TEAM on pullbacks over the next 2-6 weeks; target a 12-month move toward prior analyst estimates, but only if subsequent quarters confirm that AI attach is translating into higher ARPU/ARR per customer.
• Use a call spread in TEAM for the next earnings cycle (e.g., 3-6 month tenor) to express upside with defined risk; this is preferable to stock because valuation can re-rate quickly but guidance risk remains high.
• Pair trade: long TEAM / short a basket of slower-moving legacy collaboration or workflow software names over 3-6 months; thesis is that AI increases product usage rather than fully commoditizing the platform layer.
• For risk control, trim or hedge TEAM if the next quarter shows adoption growth without monetization uplift; that is the clearest signal the current re-rating is ahead of fundamentals.